Effect of 24 months of recombinant growth hormone on height and body proportions in SHOX haploinsufficiency

Journal of Pediatric Endocrinology and Metabolism

Volumn 16, Issue 7, 2003, Pages 997-1004

  Munns, C F J ^a,f   Berry, M ^b   Vickers, D ^c   Rappold, G A ^d   Hyland, V J ^a,e   Glass, I A ^c   Batch, J A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MATER HOSPITAL   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^f SHRINERS HOSPITAL FOR CHILDREN   (Canada)

Author keywords

Growth; Leri Weill syndrome; Madelung deformity; Short stature

Indexed keywords

HOMEODOMAIN PROTEIN; PROTEIN SHOX; RECOMBINANT GROWTH HORMONE; UNCLASSIFIED DRUG;

ADOLESCENT; ARM; ARTICLE; BODY BUILD; BODY HEIGHT; BONE AGE; BONE DENSITY; BONE DYSPLASIA; BONE MASS; CASE REPORT; DRUG EFFICACY; DRUG SAFETY; DYSCHONDROSTEOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HOMEOBOX; HORMONAL THERAPY; HUMAN; LEG LENGTH; LIPOMATOSIS; LOWER LEG; SCHOOL CHILD; SCORING SYSTEM; SHORT STATURE;

EID: 0141995074     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2003.16.7.997     Document Type: Article

References (39)

1. Galton F. The history of twins as a criterium of the relative powers of nature and nurture. J Anthropol Inst 1876.
2. Healey SC, Kirk KM, Hyland VJ, Munns CF, Henders AK, Baych JA, Heath AC, Martin NG, Glass IA. Height discordance in monozygotic females is not attributable to discordant inactivation of X-linked stature determining genes. Twin Res 2001; 4: 19-24.
3. Silventoinen K, Kaprio J, Lahelma E, Viken RJ, Rose RJ. Sex differences in genetic and environmental factors contributing to body-height. Twin Res 2001; 4: 25-29.
4. Belin V, Cusin V, Viot G, Girlich D, Toutain A, Moncla A, Vekemans M, Le Merrer M, Munnich A, Cormier-Daire V. SHOX mutations in dyschondrosteosis (Leri-Weill syndrome). Nat Genet 1998; 19: 67-69.
5. Ellison JW, Wardak Z, Young MF, Gehron Robey P, Laig-Webster M, Chiong W. PHOG, a candidate gene for involvement in the short stature of Turner syndrome. Hum Mol Genet 1997; 6: 1341-1347.
6. Huber C, Cusin V, Le Merrer M, Mathieu M, Sulmont V, Dagoneau N, Munnich A, Cormier-Daire V. SHOX point mutations in dyschondrosteosis. J Med Genet 2001; 38: 323.
7. Rao E, Weiss B, Fukami M, Rump A, Niesler B, Mertz A, Muroya K, Binder G, Kirsch S, Winkelmann M, Nordsiek G, Heinrich U, Breuning MH, Ranke MB, Rosenthal A, Ogata T, Rappold GA. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 1997; 16: 54-63.
8. Léri A, Weill J. Une affection congenitale et symetrique du development osseux: la dyschondrosteoste. Bull Mem Soc Med Hop Paris 1929; 53: 1491-1494.
9. Kosho T, Muroya K, Nagai T, Fujimoto M, Yokoya S, Sakamoto H, Hirano T, Terasaki H, Ohashi H, Nishimura G, Sato S, Matsuo N, Ogata T. Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: implications for the development of Turner syndrome. J Clin Endocrinol Metab 1999; 84: 4613-4621.
10. Schiller S, Spranger S, Schechinger B, Fukami M, Merker S, Drop SL, Troger J, Knoblauch H, Kunze J, Seidel J, Rappold GA. Phenotypic variation and genetic heterogeneity in Leri-Weill syndrome. Eur J Hum Genet 2000; 8: 54-62.
11. Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, van Teunenbroek A, Hokken-Koelega AC, Waelkens JJ, Massa GG, Vulsma T, Gerver WJ, Reeser HM, Delemarre-van de Waal HE, Jansen M, Drop SL. Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone. Arch Dis Child 1999; 80: 36-41.
12. Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Massa GG, Rouwe CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL. Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial. J Clin Endocrinol Metab 1999; 84: 4607-4612.
13. Nilsson KO, Albertsson-Wikland K, Alm J, Aronson S, Gustafsson J, Hagenas L, Hager A, Ivarsson SA, Karlberg J, Kristrom B, Marcus C, Moell C, Ritzén M, Tuvemo T, Wattsgard C, Westgren U, Westphal O, Aman J. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone. J Clin Endocrinol Metab 1996; 81: 635-640.
14. Carel JC, Mathivon L, Gendrel C, Ducret JP, Chaussain JL. Near normalization of final height with adapted doses of growth hormone in Turner's syndrome. J Clin Endocrinol Metab 1998; 83: 1462-1466.
15. Rosenfeld RG, Attie KM, Frane J, Brasel JA, Burstein S, Cara JF, Chernausek S, Gotlin RW, Kuntze J, Lippe BM, Mahoney CP, Moore WV, Saenger P, Johanson AJ. Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. J Pediatr 1998; 132: 319-324.
16. Australian Center for Health Statistics. NCHS Growth Charts. Monthly Vital Statistics Report (Suppl) (HRA) 1976; 76-1120.
17. Gerver WJ, de Bruin, R. Paediatric Morphometrics. Utrecht: Wetenschappelijke uiteverij Bunge, 1996.
18. McKusick VA. Heritable Disorders of Connective Tissue. St Louis, MO: CV Mosby Company, 1972.
19. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist. Stanford, CA: Stanford University Press, 1959.
20. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: for use with the Greulich-Pyle hand standards. J Pediatr 1952; 40: 423-441.
21. Rooney D, Czepulkowski B. Human cytogenetics - a practicle approach. Oxford: IRL Press, 1992.
22. Blaschke RJ, Rappold GA. SHOX: growth, Leri-Weill and Turner syndromes. Trends Endocrinol Metab 2000; 11: 227-230.
23. Clement-Jones M, Schiller S, Rao E, Blaschke RJ, Zuniga A, Zeller R, Robson SC, Binder G, Glass I, Strachan T, Lindsay S, Rappold GA. The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet 2000; 9: 695-702.
24. Munns CF, Glass IA, LaBrom R, Hayes M, Flanagan S, Berry M, Hyland VJ, Batch JA, Philips GE, Vickers D. Histopathological analysis of Leri-Weill dyschondrosteosis: disordered growth plate. Hand Surg 2001; 6: 13-23.
25. Shanske A, Ellison J, Vuguin P, Dowling P, Wasserman E, Heinrich J, Saenger P. Deletion of the pseudoautosomal region in a male with a unique Y;13 translocation and short stature. Am J Med Genet 1999; 82: 34-39.
26. Ogata T, Onigata K, Hotsubo T, Matsuo N, Rappold G. Growth hormone and gonadotropin-releasing hormone analog therapy in haploinsufficiency of SHOX. Endocr J 2001; 48: 317-322.
27. Binder G, Schwarze CP, Ranke MB. Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone. J Clin Endocrinol Metab 2000; 85: 245-249.
28. Cormier-Daire V, Huber C, Munnich A. Allelic and nonallelic heterogeneity in dyschondrosteosis (Leri-Weill syndrome). Am J Med Genet 2001; 106: 272-274.
29. Hagnenas L. Bone dysplasias and growth hormone treatment. In: Ranke MB, Gunnarsson R, eds. Progress in Growth Hormone Therapy. Five years of KIGS. Mannheim: J & J Verlag, 1994; 256-266.
30. Burren CP, Werther GA. Skeletal dysplasias: response to growth hormone therapy. J Pediatr Endocrinol Metab 1996; 9: 31-40.
31. Thuestad IJ, Ivarsson SA, Nilsson KO, Wattsgard C. Growth hormone treatment in Léri-Weill syndrome. J Pediatr Endocrinol Metab 1996; 9: 201-204.
32. Kanaka-Gantenbein C. Present status of the use of growth hormone in short children with bone diseases (diseases of the skeleton). J Pediatr Endocrinol Metab 2001; 14: 17-26.
33. Rosenfeld RG, Hintz RL, Johanson AJ, Sherman B, Brasel JA, Burstein S, Chernausek S, Compton P, Frane J, Gotlin RW, et al. Three-year results of a randomized prospective trial of methionyl human growth hormone and oxandrolone in Turner syndrome. J Pediatr 1988; 113: 393-400.
34. Ogata T, Wakui K, Kosho T, Muroya K, Yamanouchi Y, Takano T, Fukushima Y, Rappold G, Suzuki Y. Structural analysis of a rare rearranged Y chromosome and its bearing on genotype-phenotype correlation. Am J Med Genet 2000; 92: 256-259.
35. Musebeck J, Mohnike K, Beye P, Tonnies H, Neitzel H, Schnabel D, Grüters A, Wieacker PF, Stumm M. Short stature homeobox-containing gene deletion screening by fluorescence in situ hybridisation in patients with short stature. Eur J Pediatr 2001; 160: 561-565.
36. Reinehr T, Jauch A, Zoll B, Engel U, Bartels I, Andler W. Short stature in a mother and daughter caused by familial der(X)t(X;X)(p22.1-3;q26). Am J Med Genet 2001; 102: 81-85.
37. Ross JL, Scott C Jr, Marttila P, Kowal K, Nass A, Papenhausen P, Abboudi J, Osterman L, Kushner H, Carter P, Ezaki M, Elder F, Wei F, Chen H, Zinn AR. Phenotypes associated with SHOX deficiency. J Clin Endocrinol Metab 2001; 86: 5674-5680.
38. Adachi M, Tachibana K, Asakura Y, Muroya K, Ogata T. Del(X)(p21.1) in a mother and two daughters: genotype-phenotype correlation of Turner features. Hum Genet 2000; 106: 306-310.
39. Saenger P, Wikland KA, Conway GS, Davenport M, Gravholt CH, Hintz R, Hovatta O, Hultcrantz M, Landin-Wilhelmsen K, Lin A, Lippe B, Pasquino AM, Ranke MB, Rosenfeld R, Silberbach M. Recommendations for the diagnosis and management of Turner syndrome. J Clin Endocrinol Metab 2001; 86: 3061-3069.